Lu X, Li W, Li P, Li Y, Gou Y, Wang T
Virol J. 2025; 22(1):64.
PMID: 40050943
PMC: 11887071.
DOI: 10.1186/s12985-025-02657-2.
Murray K, Cremin M, Tay E, Sanchez K, Schreiber S, Brust-Mascher I
bioRxiv. 2025; .
PMID: 40027796
PMC: 11870408.
DOI: 10.1101/2025.02.12.637880.
Miljkovic A, Patic A, Petrovic V, Nikolic N, Kovacevic G, Pustahija T
Viruses. 2025; 17(2).
PMID: 40007027
PMC: 11860240.
DOI: 10.3390/v17020272.
Han S, Kubo Y, Robert A, Baguelin M, Ariyoshi K
Viruses. 2025; 17(2).
PMID: 40006908
PMC: 11861327.
DOI: 10.3390/v17020152.
Roeke K, Howard K
Membranes (Basel). 2025; 15(2).
PMID: 39997666
PMC: 11857740.
DOI: 10.3390/membranes15020040.
Vaccine effectiveness against influenza B/Victoria-associated medically attended influenza-like illness: Beijing, China, 2021-2022 influenza season.
Ma C, Sun Y, Zhang L, Zhang J, Duan W, Li J
Hum Vaccin Immunother. 2025; 21(1):2460859.
PMID: 39971488
PMC: 11844929.
DOI: 10.1080/21645515.2025.2460859.
Hospitalisation from seasonal influenza among persons with type 1 diabetes: a cohort study from the Swedish National Diabetes Register.
Kjolhede E, Carlsen H, Martyn O, Svensson L, Gisslen M, Eliasson B
BMJ Open. 2025; 15(2):e084165.
PMID: 39933818
PMC: 11815461.
DOI: 10.1136/bmjopen-2024-084165.
Comparison of Respiratory Microbiomes in Influenza Versus Other Respiratory Infections: Systematic Review and Analysis.
Hao Y, Lee Y, Yap K, Samuel M, Chow V
Int J Mol Sci. 2025; 26(2).
PMID: 39859492
PMC: 11765715.
DOI: 10.3390/ijms26020778.
Effectiveness of Antiviral Treatment with Intravenous Peramivir and Oral Oseltamivir for Seasonal Influenza in Children.
Byun Y, Kim J, Paek S, Kim M, Park S, Song H
Children (Basel). 2025; 12(1).
PMID: 39857857
PMC: 11763945.
DOI: 10.3390/children12010026.
TRIF-TAK1 signaling suppresses caspase-8/3-mediated GSDMD/E activation and pyroptosis in influenza A virus-infected airway epithelial cells.
Sun Y, Yu H, Zhan Z, Liu W, Liu P, Sun J
iScience. 2025; 28(1):111581.
PMID: 39811662
PMC: 11732511.
DOI: 10.1016/j.isci.2024.111581.
Antiviral Medications for Treatment of Nonsevere Influenza: A Systematic Review and Network Meta-Analysis.
Gao Y, Zhao Y, Liu M, Luo S, Chen Y, Chen X
JAMA Intern Med. 2025; 185(3):293-301.
PMID: 39804622
PMC: 11877164.
DOI: 10.1001/jamainternmed.2024.7193.
Porphyromonas gingivalis gingipain potentially activates influenza A virus infectivity through proteolytic cleavage of viral hemagglutinin.
Kamio N, Cueno M, Takagi A, Imai K
J Biol Chem. 2025; 301(2):108166.
PMID: 39793895
PMC: 11834065.
DOI: 10.1016/j.jbc.2025.108166.
Modulation of cytokeratin and cytokine/chemokine expression following influenza virus infection of differentiated human tonsillar epithelial cells.
Perry S, Brice D, Sakr A, Kandeil A, DeBeauchamp J, Ghonim M
J Virol. 2025; 99(2):e0146024.
PMID: 39791909
PMC: 11852761.
DOI: 10.1128/jvi.01460-24.
Debulking influenza and herpes simplex virus strains by a wide-spectrum anti-viral protein formulated in clinical grade chewing gum.
Daniell H, Guo Y, Singh R, Karki U, Kulchar R, Wakade G
Mol Ther. 2024; 33(1):184-200.
PMID: 39663701
PMC: 11764783.
DOI: 10.1016/j.ymthe.2024.12.008.
Antiviral activity of the water extract and ethanol extract of against influenza A virus .
Kim Y, Lee S, Kim C, Yoon S, Jeon S, Kweon M
Heliyon. 2024; 10(20):e39049.
PMID: 39640637
PMC: 11620158.
DOI: 10.1016/j.heliyon.2024.e39049.
Protective Impact of Influenza Vaccination on Healthcare Workers.
Tian Y, Ma Y, Ran J, Yuan L, Zeng X, Tan L
Vaccines (Basel). 2024; 12(11).
PMID: 39591140
PMC: 11599008.
DOI: 10.3390/vaccines12111237.
Protecting the elderly from influenza in the context of immune system senescence. Elderly aged 65 and over are vulnerable to influenza and its associated complications.: Position paper by the Romanian Society of Gerontology and Geriatrics.
Prada G, Bajenaru O, Chelu G, Matei-Linca C, Nuta C, Moscu S
J Med Life. 2024; 17(7):746-754.
PMID: 39440332
PMC: 11493167.
DOI: 10.25122/jml-2024-0274.
Ethanolic Extract from (L.) Moench Inhibits Influenza A/B and Respiratory Syncytial Virus Infection : Preventive Agent for Viral Respiratory Infections.
Lee S, Lee D, Min D, Park S, Kim D, Kim E
Prev Nutr Food Sci. 2024; 29(3):332-344.
PMID: 39371516
PMC: 11450288.
DOI: 10.3746/pnf.2024.29.3.332.
A Single-Component Multilayered Self-Assembling Protein Nanoparticle Vaccine Based on Extracellular Domains of Matrix Protein 2 against Both Influenza A and B.
Zhang Y, Gomes K, Lee Y, Ward G, Xie B, Auclair S
Vaccines (Basel). 2024; 12(9).
PMID: 39340007
PMC: 11435909.
DOI: 10.3390/vaccines12090975.
A post-marketing study to evaluate the safety and immunogenicity of a quadrivalent influenza split-virion vaccine in elderly people aged 60 years and older.
Kou Z, Li X, Liu T, Fan B, An W, An W
Trop Dis Travel Med Vaccines. 2024; 10(1):18.
PMID: 39277739
PMC: 11402193.
DOI: 10.1186/s40794-024-00228-x.